Tenax Therapeutics, INC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
NASDAQ
SCHEDULE: Tenax Therapeutics: Giordano Exits Stake
Christopher Thomas Giordano has filed an amendment to Schedule 13D, indicating an exit from his beneficial ownership of Tenax Therapeutics common stock.